The activity profile of the hexacyclic camptothecin derivative DX-8951f in experimental human colon cancer and ovarian cancer
DX-8951f or exatecan mesylate ((1 S,9 S)-1-amino-9-ethyl-5-fluoro-2,3-dihydro-9-hydroxy-4-methyl-1 H,12 H-benzo[ de]pyrano[3′,4′:6,7]indolizino[1,2- b]quinoline-10-13(9 H,15 H)-dione methanesulfonate dihydrate), is a new water-soluble derivative of camptothecin. We determined the activity of DX-8951...
Gespeichert in:
Veröffentlicht in: | Biochemical pharmacology 2002-10, Vol.64 (8), p.1267-1277 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | DX-8951f or exatecan mesylate ((1
S,9
S)-1-amino-9-ethyl-5-fluoro-2,3-dihydro-9-hydroxy-4-methyl-1
H,12
H-benzo[
de]pyrano[3′,4′:6,7]indolizino[1,2-
b]quinoline-10-13(9
H,15
H)-dione methanesulfonate dihydrate), is a new water-soluble derivative of camptothecin. We determined the activity of DX-8951f in experimental human colon cancer and ovarian cancer, being tumor types sensitive to camptothecins. With the use of the MTT assay, DX-8951f was more potent than SN-38 in four out of five human colon cancer cell lines and three out of four human ovarian cancer cell lines (
P |
---|---|
ISSN: | 0006-2952 1873-2968 |
DOI: | 10.1016/S0006-2952(02)01297-2 |